Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Innovative Stent Graft System Treats AAA

By HospiMedica International staff writers
Posted on 20 Dec 2018
An ultra-low profile endovascular aneurysm repair (EVAR) system prevents infrarenal abdominal aortic aneurysm (AAA) rupture in a wide range of patient populations.

The Cordis (Fremont, CA, USA) INCRAFT AAA system is a modular, bifurcated EVAR system composed of an aortic bifurcate prosthesis and two iliac limb prostheses, each preloaded into its own delivery system. More...
The prostheses are advanced to the intended location over a 0.035” stiff guide wire and under fluoroscopy, aided by radiopaque markers. Once in position, they are deployed to exclude the AAA sac from blood flow. While each patient receives an aortic bifurcated prosthesis and two iliac limb prostheses, additional iliac limb prostheses can be used to extend the device caudally, if needed.

The aortic bifurcate prosthesis itself (available in four diameters) has a flared bare crown with 8 or 10 laser-cut barbs designed to provide fixation in the aorta. The trunk has two sealing stents and a taper stent that divides into the ipsilateral and contralateral legs, each with a series of z-stents supporting the graft material. An integrated sheath introducer, along with a hemostatic valve, facilitates introduction of the aortic bifurcate delivery system and also of the iliac limb delivery system, respectively, into the vasculature.

The iliac limb prosthesis is composed of a series of z-stents, one or more taper stents (if other than a straight configuration), and a caudal diamond or z-stent for sealing. The iliac limb delivery system can be delivered through the integrated sheath introducer of the aortic bifurcate system to ease introduction into the vasculature. All stent grafts are constructed of a woven polyester graft supported by a series of laser-cut, electro-polished, self-expanding nitinol stent-rings, which are sutured internally throughout the implant’s entire length.

“We are excited to announce INCRAFT FDA approval, which will enable high-risk AAA patients in the United States to benefit from more than a decade of investment in research and development and clinical research,” said Patrick Holt, president of Cordis, a part of Cardinal Health (Dublin, OH, USA). “Cordis continues to invest in expanding our product offering to meet our global customers’ needs.”

AAA is the localized dilatation of the abdominal aorta exceeding the normal diameter by more than 50%, and is the most common form of aortic aneurysm; approximately 90% occur below the kidneys. The aneurysms can extend to include one or both of the pelvic iliac arteries. The major complication of AAA is rupture, which is life-threatening, as large amounts of blood spill into the abdominal cavity, and can lead to death within minutes. Mortality of rupture repair in the hospital is 60-90%.


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.